143 related articles for article (PubMed ID: 18790788)
21. Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.
Miyamoto Y; Muguruma N; Fujimoto S; Okada Y; Kida Y; Nakamura F; Tanaka K; Nakagawa T; Kitamura S; Okamoto K; Miyamoto H; Sato Y; Takayama T
Cancer Sci; 2019 Jun; 110(6):1921-1930. PubMed ID: 30973663
[TBL] [Abstract][Full Text] [Related]
22. Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
Lee AF; Chen MC; Chen CJ; Yang CJ; Huang MS; Liu YP
PLoS One; 2017; 12(7):e0180383. PubMed ID: 28683123
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor inhibition downregulates
Sierra JC; Asim M; Verriere TG; Piazuelo MB; Suarez G; Romero-Gallo J; Delgado AG; Wroblewski LE; Barry DP; Peek RM; Gobert AP; Wilson KT
Gut; 2018 Jul; 67(7):1247-1260. PubMed ID: 28473630
[TBL] [Abstract][Full Text] [Related]
24. Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
Bai XY; Zhang XC; Yang SQ; An SJ; Chen ZH; Su J; Xie Z; Gou LY; Wu YL
PLoS One; 2016; 11(3):e0149370. PubMed ID: 26943330
[TBL] [Abstract][Full Text] [Related]
25. Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation.
Ly P; Kim SB; Kaisani AA; Marian G; Wright WE; Shay JW
Oncogene; 2013 Jun; 32(26):3139-46. PubMed ID: 22890317
[TBL] [Abstract][Full Text] [Related]
26. Expression of the human antimicrobial peptide β-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.
Bonamy C; Sechet E; Amiot A; Alam A; Mourez M; Fraisse L; Sansonetti PJ; Sperandio B
Sci Rep; 2018 Dec; 8(1):18043. PubMed ID: 30575780
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase.
Okabe T; Okamoto I; Tsukioka S; Uchida J; Iwasa T; Yoshida T; Hatashita E; Yamada Y; Satoh T; Tamura K; Fukuoka M; Nakagawa K
Mol Cancer Ther; 2008 Mar; 7(3):599-606. PubMed ID: 18347146
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.
Bonine-Summers AR; Aakre ME; Brown KA; Arteaga CL; Pietenpol JA; Moses HL; Cheng N
Cancer Biol Ther; 2007 Apr; 6(4):561-70. PubMed ID: 17495520
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of DKK3 by miR-483-3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins.
Guo J; Yang Z; Zhou H; Yue J; Mu T; Zhang Q; Bi X
Mol Carcinog; 2020 Feb; 59(2):168-178. PubMed ID: 31763724
[TBL] [Abstract][Full Text] [Related]
30. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.
Velmurugan B; Singh RP; Tyagi A; Agarwal R
Cancer Prev Res (Phila); 2008 Oct; 1(5):376-84. PubMed ID: 19138982
[TBL] [Abstract][Full Text] [Related]
32. Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.
Vlotides G; Siegel E; Donangelo I; Gutman S; Ren SG; Melmed S
Cancer Res; 2008 Aug; 68(15):6377-86. PubMed ID: 18676863
[TBL] [Abstract][Full Text] [Related]
33. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
Nishimura Y; Yoshioka K; Bereczky B; Itoh K
Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.
Deb TB; Coticchia CM; Barndt R; Zuo H; Dickson RB; Johnson MD
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C365-77. PubMed ID: 18562482
[TBL] [Abstract][Full Text] [Related]
35. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
36. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
[TBL] [Abstract][Full Text] [Related]
37. SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivo.
Pan Y; Xu Y; Feng S; Luo S; Zheng R; Yang J; Wang L; Zhong L; Yang HY; Wang BL; Yu Y; Liu J; Cao Z; Wang X; Ji P; Wang Z; Chen X; Zhang S; Wei YQ; Yang SY
Mol Cancer Ther; 2012 Apr; 11(4):952-62. PubMed ID: 22319204
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
39. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
40. The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
Braun AH; Stark K; Dirsch O; Hilger RA; Seeber S; Vanhoefer U
Anticancer Drugs; 2005 Nov; 16(10):1099-108. PubMed ID: 16222152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]